Fortis Malar Hospitals Ltd

Fortis Malar Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Fortis Malar Hospitals Ltd

₹ 61.4 0.79%
27 Dec 4:01 p.m.
fortismalar.com BSE: 523696
About

Incorporated in 1992, Fortis Malar Hospital Ltd is in the business of providing health care & medical services[1]

Key Points

Business Overview:[1][2]
Company is a part of Fortis Group, being subsidiary of Fortis Hospitals Limited and Intermediate Holding Company of Fortis Healthcare Ltd. The Hospital building is owned by a fellow subsidiary, Fortis Health Management Limited. Company has entered into Hospital and Medical Services Agreement
with FHML for rendering of medical and healthcare services at the hospital building

Website BSE
  • Market Cap ₹ 115 Cr.
  • Current Price ₹ 61.4
  • High / Low ₹ 108 / 44.0
  • Stock P/E
  • Book Value ₹ 15.9
  • Dividend Yield 69.2 %
  • ROCE -3.29 %
  • ROE -9.12 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company has reduced debt.
  • Company is almost debt free.
  • Stock is providing a good dividend yield of 69.2%.

Cons

  • Stock is trading at 3.86 times its book value
  • Company has low interest coverage ratio.
  • The company has delivered a poor sales growth of -16.4% over past five years.
  • Company has a low return on equity of -13.0% over last 3 years.
  • Earnings include an other income of Rs.62.3 Cr.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Healthcare Industry: Healthcare

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024
19.93 20.45 22.62 20.10 23.29 21.90 20.66 17.76 18.15 17.58 5.52 0.00 0.00
20.93 20.19 19.35 20.13 21.01 20.30 19.93 18.27 18.23 18.67 5.04 0.88 0.47
Operating Profit -1.00 0.26 3.27 -0.03 2.28 1.60 0.73 -0.51 -0.08 -1.09 0.48 -0.88 -0.47
OPM % -5.02% 1.27% 14.46% -0.15% 9.79% 7.31% 3.53% -2.87% -0.44% -6.20% 8.70%
1.99 1.77 1.58 1.64 1.50 1.52 1.97 1.61 2.31 1.26 59.69 0.83 0.56
Interest 1.67 1.61 1.55 1.55 1.61 1.49 1.42 1.35 1.30 1.26 0.39 0.01 0.00
Depreciation 3.09 3.12 3.24 3.02 2.91 2.78 3.44 2.67 2.72 2.91 1.06 0.00 0.00
Profit before tax -3.77 -2.70 0.06 -2.96 -0.74 -1.15 -2.16 -2.92 -1.79 -4.00 58.72 -0.06 0.09
Tax % 0.00% 0.00% 850.00% 0.00% 491.89% 0.00% 223.15% 0.00% 0.00% 0.25% 7.95% 0.00% 0.00%
-3.78 -2.70 -0.45 -2.96 -4.38 -1.15 -6.99 -2.93 -1.79 -4.00 54.05 -0.06 0.09
EPS in Rs -2.02 -1.44 -0.24 -1.58 -2.34 -0.61 -3.73 -1.56 -0.96 -2.13 28.84 -0.03 0.05
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 TTM
98 108 118 130 141 149 145 112 69 86 86 59 23
86 99 110 123 140 147 147 115 76 83 81 60 25
Operating Profit 11 9 8 6 1 2 -2 -3 -6 3 5 -1 -2
OPM % 12% 8% 6% 5% 1% 1% -2% -2% -9% 4% 5% -2% -8%
49 7 8 7 8 8 10 11 15 7 7 65 62
Interest 1 0 1 0 0 0 1 8 7 7 6 4 2
Depreciation 2 2 3 3 4 4 4 13 13 13 12 9 4
Profit before tax 57 13 12 10 4 6 3 -12 -11 -8 -7 50 55
Tax % 24% 34% 34% 36% 30% 41% 26% -25% -30% 0% 121% 9%
43 9 8 6 3 3 2 -9 -8 -8 -15 45 50
EPS in Rs 23.38 4.72 4.23 3.45 1.67 1.78 1.10 -4.74 -4.20 -4.41 -8.26 24.18 26.73
Dividend Payout % 0% 11% 12% 14% 0% 0% 0% 0% 0% 0% 0% 176%
Compounded Sales Growth
10 Years: -6%
5 Years: -16%
3 Years: -5%
TTM: -71%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: 14%
TTM: 75%
Stock Price CAGR
10 Years: 6%
5 Years: 5%
3 Years: -1%
1 Year: 3%
Return on Equity
10 Years: -3%
5 Years: -13%
3 Years: -13%
Last Year: -9%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Sep 2024
Equity Capital 19 19 19 19 19 19 19 19 19 19 19 19 19
Reserves 59 66 73 79 81 84 87 78 70 61 45 91 11
0 0 0 0 0 0 0 64 57 53 46 0 0
14 17 20 33 31 46 45 33 23 27 27 6 7
Total Liabilities 91 101 111 130 131 149 151 194 169 161 138 116 37
17 18 18 24 25 24 22 81 69 58 47 0 0
CWIP 0 1 1 0 1 1 1 0 0 0 0 0 0
Investments 0 0 0 0 0 0 0 0 0 0 0 0 0
73 83 93 105 105 125 128 112 100 103 91 116 37
Total Assets 91 101 111 130 131 149 151 194 169 161 138 116 37

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
-64 5 4 10 -9 9 -16 -0 -1 7 6 -7
73 -1 5 -22 13 -2 6 50 -28 8 0 120
-7 -1 0 -1 -1 0 0 -12 -7 -10 -13 -11
Net Cash Flow 2 3 10 -13 4 7 -9 38 -36 5 -7 102

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Debtor Days 12 13 13 17 14 15 24 12 11 9 14 0
Inventory Days 7 4 13 35 28 22 18 22 42 40 32 0
Days Payable 160 153 169 286 174 277 257 324 373 429 585
Cash Conversion Cycle -141 -136 -143 -234 -131 -240 -215 -289 -320 -380 -539 0
Working Capital Days 212 187 164 126 153 132 156 -55 134 51 219 -8
ROCE % 23% 17% 14% 12% 5% 6% 3% -3% -7% -1% -1% -3%

Shareholding Pattern

Numbers in percentages

Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
62.71% 62.71% 62.71% 62.71% 62.71% 62.71% 62.71% 62.71% 62.71% 62.71% 14.40% 62.71%
0.07% 0.07% 0.07% 0.07% 0.07% 0.07% 0.07% 0.07% 0.07% 0.07% 0.17% 0.07%
37.22% 37.22% 37.22% 37.23% 37.23% 37.23% 37.23% 37.23% 37.23% 37.23% 85.43% 37.22%
No. of Shareholders 9,3659,6889,5789,5208,7728,7318,6518,6309,79010,21316,45218,860

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports